Kamran Alam
Overview
Kamran Alam received an average of $2M in total compensation, including $337K in salary, at Taysha Gene Therapies from 2020 to 2023. Kamran Alam also received $2M at Inotek Pharmaceuticals in 2019 and an average of $1M at Aquinox Pharmaceuticals from 2015 to 2019.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
Taysha Gene TherapiesChief Financial Officer
Taysha Gene TherapiesChief Financial Officer
Taysha Gene TherapiesChief Financial Officer
Taysha Gene TherapiesChief Financial Officer
Aquinox PharmaceuticalsInterim Chief Financial Officer and Vice President, Finance
Inotek PharmaceuticalsSenior Vice President – Finance and Principal Financial Officer
Aquinox PharmaceuticalsInterim Chief Financial Officer and Vice President, Finance
Aquinox PharmaceuticalsChief Financial Officer and Vice President, Finance
Aquinox PharmaceuticalsChief Financial Officer and Vice President, Finance
Aquinox PharmaceuticalsChief Financial Officer and Vice President, Finance
Source: SEC filings on April 18, 2024, May 8, 2023, April 28, 2022, March 24, 2020, April 24, 2020, October 2, 2019, and March 26, 2018.
Related executives
We found 19 more executives who work or worked at Taysha Gene Therapies, Inotek Pharmaceuticals, andAquinox Pharmaceuticals.
Sean Nolan
Taysha Gene Therapies
Chief Executive Officer
Sukumar Nagendran
Taysha Gene Therapies
President and Head of Research and Development
RA Session
Taysha Gene Therapies
Chief Executive Officer
Priti Patel
Aquinox Pharmaceuticals
Chief Medical Officer
Jonathan Drachman
Aquinox Pharmaceuticals
Chief Executive Officer
Suyash FFPM
Taysha Gene Therapies
Chief Medical Officer
Robert Ho
Aquinox Pharmaceuticals
Chief Financial Officer
Gaurav Shah
Inotek Pharmaceuticals
Chief Executive Officer
News
Taysha Gene Therapies CEO Sean Nolan's 2023 pay slips 20% to $1.5M
April 18, 2024
Taysha Gene Therapies CEO RA Session's 2022 pay falls 57% to $2M
May 8, 2023
Taysha Gene Therapies CEO RA Session's 2021 pay slips 3% to $4.6M
April 28, 2022
Inotek Pharmaceuticals CEO Gaurav Shah's 2019 pay falls 39% to $3.9M
April 24, 2020
Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
March 24, 2020
Aquinox Pharmaceuticals CEO David Main's 2018 pay jumps 39% to $4.2M
October 2, 2019